Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine
Conditions: Enterovirus Infections; Influenza Interventions: Biological: EV71 vaccine and influenza vaccine; Biological: EV71 vaccine; Biological: influenza vaccine Sponsors: China National Biotec Group Company Limited; Zhejiang Provincial Center for Disease Control and Prevention; Henan Center for Disease Control and Prevention; Guizhou Center for Disease Control and Prevention; Wuhan Institute of Biological Products Co., Ltd; C hangchun Institute of Biological Products Co., Ltd.; Peking University; National Institutes for Food and Drug Control, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Centers for Disease Control and Prevention (CDC) | China Health | Influenza | Influenza Vaccine | Research | Vaccines